Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Faeth Therapeutics, Inc. FTH

Set alert

Price alert · FTH

All alert types
19.29 USD +0.60 +3.21%

As of Nov 2, 3:31 PM ET

Bid
19.24 × 1
Ask
20.00 × 2
18.36 Day range 20.01
7.45 52-week range 42.14
YTD
+80.79%
1 year
+110.36%
Open
18.69
Prev close
18.69
Mkt cap
502.85M
Vol
171.84K
Avg vol
374.70K
EPS
-60.86
P/E
0.00
Div yield
0.00%
More statistics
Low
18.36
High
20.01
Forward P/E
-7.88
Beta
-0.28
Short ratio
3.64
Inst. own
78.84%
Dividend
0.00
Ex-div date
Earnings
Nov 13, 2026
50-d avg
30.99
200-d avg
22.28
1y target
54.64

3M chart

Chart tools
Interval
1m5m15m30m

Events in this range
  • Aug 4, 2026Earnings: -2.84; estimate -2.64; surprise -7.58%
  • Aug 4, 2026Rating: Jones Trading · — → Buy
  • Aug 11, 2026Rating: HC Wainwright & Co. · Buy → Buy
  • Aug 21, 2026Rating: Needham · — → Buy
  • Sep 9, 2026Rating: TD Cowen · — → Buy
  • Sep 14, 2026Rating: LUCID CAPITAL MARKETS · — → Buy
Signals (10)
NameDateAgo
MACD: Buy SignalOct 29, 20264 days ago
RSI: OversoldOct 23, 20261 week ago
RSI: OversoldOct 13, 20262 weeks ago
SMA: BearishSep 23, 20261 month ago
SMA: BearishSep 21, 20261 month ago
MACD: Sell SignalSep 15, 20261 month ago
RSI: OverboughtSep 2, 20262 months ago
MACD: Buy SignalAug 14, 20262 months ago
SMA: BullishAug 10, 20262 months ago
SMA: BearishAug 3, 20263 months ago

Financial health

Altman Z-Score

11.91 Safe zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

2 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

B-3 / 5 overall

  • DCF 3
  • Return on Equity 1
  • Return on Assets 1
  • Debt / Equity 4
  • P/E 1
  • P/B 5

Valuation

P/E -0.6×
FY 2018: -32.9×FY 2019: -27.0×FY 2020: -28.6×FY 2021: -4.4×FY 2022: -0.9×FY 2023: -0.6×FY 2024: -0.4×FY 2025: -0.6×
FY 2018 5y median -0.6× FY 2025
P/S 0.0×
FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2018 5y median 0.0× FY 2025
P/B 0.7×
FY 2018: -10.4×FY 2019: -8.1×FY 2020: 36.4×FY 2021: 1.1×FY 2022: 0.4×FY 2023: 0.3×FY 2024: 0.3×FY 2025: 0.7×
FY 2018 5y median 0.4× FY 2025
P/FCF -0.7×
FY 2018: -53.6×FY 2019: -64.3×FY 2020: -30.6×FY 2021: -5.0×FY 2022: -1.2×FY 2023: -0.6×FY 2024: -0.5×FY 2025: -0.7×
FY 2018 5y median -0.7× FY 2025
EV/EBITDA -0.3×
FY 2018: -44.0×FY 2019: -39.6×FY 2020: -30.9×FY 2021: -4.4×FY 2022: -0.8×FY 2023: -0.4×FY 2024: -0.2×FY 2025: -0.3×
FY 2018 5y median -0.4× FY 2025
EV/Sales 0.0×
FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2018 5y median 0.0× FY 2025
FCF Yield -152.2%
FY 2018: -1.9%FY 2019: -1.6%FY 2020: -3.3%FY 2021: -20.1%FY 2022: -86.0%FY 2023: -166.5%FY 2024: -201.6%FY 2025: -152.2%
FY 2018 5y median -152.2% FY 2025

Profitability

Gross Margin 0.0%
FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2018 5y median 0.0% FY 2025
Operating Margin 0.0%
FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2018 5y median 0.0% FY 2025
Net Margin 0.0%
FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2018 5y median 0.0% FY 2025
ROE -113.4%
FY 2018: 24.4%FY 2019: 24.4%FY 2020: -126.5%FY 2021: -25.1%FY 2022: -47.0%FY 2023: -52.5%FY 2024: -78.6%FY 2025: -113.4%
FY 2018 5y median -52.5% FY 2025
ROIC -110.9%
FY 2018: 10888.9%FY 2019: 279.9%FY 2020: -117.0%FY 2021: -25.2%FY 2022: -44.1%FY 2023: -52.1%FY 2024: -75.0%FY 2025: -110.9%
FY 2018 5y median -52.1% FY 2025
ROA -92.1%
FY 2018: -704.8%FY 2019: -1375.5%FY 2020: -93.8%FY 2021: -24.0%FY 2022: -41.0%FY 2023: -45.9%FY 2024: -66.5%FY 2025: -92.1%
FY 2018 5y median -45.9% FY 2025

Growth (YoY)

Revenue 0.0%
FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2018 FY 2025
Operating Income 29.6%
FY 2018: 0.0%FY 2019: 2.4%FY 2020: -56.4%FY 2021: -92.7%FY 2022: -31.0%FY 2023: 24.5%FY 2024: 14.6%FY 2025: 29.6%
FY 2018 FY 2025
EPS (diluted) 30.4%
FY 2018: 0.0%FY 2019: -21.9%FY 2020: 5.7%FY 2021: -101.1%FY 2022: -19.2%FY 2023: 22.9%FY 2024: 1.6%FY 2025: 30.4%
FY 2018 FY 2025
Free Cash Flow 17.5%
FY 2018: 0.0%FY 2019: 16.6%FY 2020: -119.3%FY 2021: -70.7%FY 2022: -21.9%FY 2023: 18.2%FY 2024: 22.9%FY 2025: 17.5%
FY 2018 FY 2025

Financial Health

Current Ratio 5.1×
FY 2018: 0.5×FY 2019: 0.0×FY 2020: 4.2×FY 2021: 30.4×FY 2022: 12.0×FY 2023: 11.9×FY 2024: 7.7×FY 2025: 5.1×
FY 2018 5y median 11.9× FY 2025
Quick Ratio 5.1×
FY 2018: 0.5×FY 2019: 0.0×FY 2020: 4.2×FY 2021: 30.4×FY 2022: 12.0×FY 2023: 11.9×FY 2024: 7.7×FY 2025: 5.1×
FY 2018 5y median 11.9× FY 2025
Debt / Equity 0.1×
FY 2018: -0.1×FY 2019: -0.2×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.1×FY 2023: 0.1×FY 2024: 0.1×FY 2025: 0.1×
FY 2018 5y median 0.1× FY 2025
Net Debt / EBITDA 0.3×
FY 2018: -0.3×FY 2019: -1.1×FY 2020: 0.9×FY 2021: 0.1×FY 2022: 0.2×FY 2023: 0.2×FY 2024: 0.2×FY 2025: 0.3×
FY 2018 5y median 0.2× FY 2025
Interest Coverage -697×
FY 2018: -39.0×FY 2019: -5.5×FY 2020: -11.5×FY 2021: -55.9×FY 2022: -224×FY 2023: -257×FY 2024: -352×FY 2025: -697×
FY 2018 5y median -257× FY 2025

Dividends

Dividend Yield 0.0%
FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2018 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2018 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31